Resources

By Francis Gano Benedict, Elliott Proctor Joslin PART I. INTRODUCTION.   Perhaps no chronic disease makes such rapid inroads on health, strength, and weight as does diahetes. The large amounts of sugar in the urine, the polydipsia, polyphagia, and polyuria are observations so common in many cases that it is …

Lana Kravarusic Doctor of Pharmacy Candidate, University of Florida 

Cycloset New First in Class Type 2 Diabetes Drug Cycloset Available November 2010. VeroScience announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize Cycloset®, which has been approved by the FDA as an adjunct to diet and exercise to improve …

Amyloid could “directly poison” pancreas cells. Shedding light on how a malfunctioning protein helps trigger Type 2 diabetes could one day offer the chance to halt the damage, say scientists…. 

VeroScience announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize Cycloset®, which has been approved by the FDA as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes both as mono-therapy and in …

Urban air pollution — especially the particles and gases spewed by heavy traffic — can increase a person’s risk of developing Type 2 diabetes according to a new German study. People with chronic inflammation may be especially vulnerable…

More evidence for dentists being part of the diabetes team: cardiologists and other physicians who manage patients with CVD should collaborate with dentists to moderate cardiovascular risk in patients who also suffer from periodontitis… 

A lifestyle intervention incorporating exercise training and diet counseling in primary health care settings appears to improve quality of life among adults at moderate to high risk for heart disease and appears cost-effective compared to standard care, according to a report… 

A higher rate of hypersensitivity and GI intolerability was seen with taspoglutide…

Treating intensive care patients who develop life-threatening bacterial infections, or septicemia, with insulin potentially could reduce their chances of succumbing to the infection, if results of a new preliminary study can be replicated in a larger study…